Ampio Pharmaceuticals, Inc. (AMPE) DCF Valuation

Ampio Pharmaceuticals, Inc. (AMPE) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Ampio Pharmaceuticals, Inc. (AMPE) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of Ampio Pharmaceuticals, Inc. (AMPE) with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and evaluate how changes affect Ampio's valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -17.3 .0 .0 -18.3 .0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 1.3 1.2 1.1 2.1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -18.6 -1.2 -1.1 -20.4 -.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 6.5 17.3 33.9 12.7 4.1 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .2 .0 .0 .9
Account Receivables, % 100 100 100 100 100
Inventories .0 .3 1.2 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .2 .2 .4 .1 .8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -11.8 -1.2 -.8 -10.6 -.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -10.4 -.5 -.3 -7.6 -.3 .2 .0 .0 .0 .0
WACC, % 2.86 4.48 3.28 2.34 4.48 3.49 3.49 3.49 3.49 3.49
PV UFCF
SUM PV UFCF .2
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -4
Equity Value 4
Diluted Shares Outstanding, MM 1
Equity Value Per Share 4.91

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to create various scenarios tailored to Ampio Pharmaceuticals, Inc. (AMPE).
  • Real-World Data: Ampio’s financial data pre-filled to kickstart your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value specifically for Ampio Pharmaceuticals, Inc. (AMPE).
  • Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and pricing strategies.
  • Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other financial metrics.
  • High-Precision Accuracy: Incorporates Ampio Pharmaceuticals' real-world data for credible valuation results.
  • Effortless Scenario Analysis: Easily evaluate various assumptions and analyze outcomes side by side.
  • Efficiency Booster: Avoid the complexities of creating detailed valuation models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file featuring Ampio Pharmaceuticals, Inc. (AMPE) preloaded data.
  • 2. Adjust Assumptions: Modify key parameters such as projected growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation scenarios.
  • 5. Present with Assurance: Share professional valuation insights to bolster your decision-making process.

Why Choose This Calculator for Ampio Pharmaceuticals, Inc. (AMPE)?

  • Accuracy: Utilizes real Ampio financial data to ensure precise calculations.
  • Flexibility: Allows users to easily adjust and test various input parameters.
  • Time-Saving: Eliminates the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and precision expected at the CFO level.
  • User-Friendly: Designed for ease of use, suitable for both novice and experienced financial analysts.

Who Should Use This Product?

  • Pharmaceutical Students: Discover drug development processes and apply them using real-world case studies.
  • Researchers: Integrate cutting-edge models into your studies or publications.
  • Investors: Evaluate your own predictions and assess valuation scenarios for Ampio Pharmaceuticals, Inc. (AMPE).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for the biotech sector.
  • Healthcare Entrepreneurs: Understand how public biotech companies like Ampio are evaluated and positioned in the market.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Ampio Pharmaceuticals historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Ampio Pharmaceuticals, Inc. (AMPE).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.